Functional Analysis of CTCF During Mammalian Limb Development  by Soshnikova, Natalia et al.
Developmental Cell
ArticleFunctional Analysis of CTCF
During Mammalian Limb Development
Natalia Soshnikova,1 Thomas Montavon,2 Marion Leleu,2 Niels Galjart,3 and Denis Duboule1,2,*
1Department of Zoology and Animal Biology, University of Geneva, Sciences III, 1211 Geneva 4, Switzerland
2School of Life Sciences, Ecole Polytechnique Fe´de´rale, 1015 Lausanne, Switzerland
3Department of Cell Biology and Genetics, Erasmus MC, 3000 DR Rotterdam, the Netherlands
*Correspondence: denis.duboule@epfl.ch or denis.duboule@unige.ch
DOI 10.1016/j.devcel.2010.11.009SUMMARY
CCCTC-binding factor (CTCF) is a nuclear zinc-finger
protein that displays insulating activity in a variety of
biological assays. For example, CTCF-binding sites
have been suggested to isolate Hox gene clusters
from neighboring transcriptional interference. We
investigated this issue during limb development,
where Hoxd genes must remain isolated from long-
range effects to allow essential regulation within
independent sub-groups. We used conditional Ctcf
inactivation in incipient forelimbs and show that
the overall pattern of Hoxd gene expression remains
unchanged. Transcriptome analysis using tiling
arrays covering chromosomes 2 and X confirmed
the weak effect of CTCF depletion on global gene
regulation. However, Ctcf deletion caused massive
apoptosis, leading to a nearly complete loss of limb
structure at a later stage. We conclude that, at least
in this physiological context, rather than being an
insulator, CTCF is required for cell survival via the
direct transcriptional regulation of target genes
critical for cellular homeostasis.
INTRODUCTION
CCCTC-binding factor (CTCF) is a ubiquitous zinc-finger protein
with a remarkable structural conservation among many animal
species (reviewed in Phillips and Corces, 2009; Ohlsson et al.,
2010). CTCF regulates multiple genes and can act either as
a repressor, by recruiting the Sin3a histone deacetylase and
YB-1 transcription factor to target genes (Lutz et al., 2000;
Chernukhin et al., 2000), or as an activator by modulating long-
range chromatin interactions between enhancers and promoters
via intrachromosomal loops (Majumder et al., 2008; Hadjur et al.,
2009). These loops may be established either through the
formation of CTCF homodimers bound to different genomic
loci (Pant et al., 2004; Yusufzai et al., 2004), or via cohesin
complexes recruited to DNA in a CTCF-dependent manner
(Parelho et al., 2008; Wendt et al., 2008).
The function of CTCF has been investigated in detail during
the control of differential gene expression within the Igf2/H19
imprinted locus (Bell and Felsenfeld, 2000; Hark et al., 2000).DevelopmeAt this locus, the same enhancers are required for the activation
of both genes, and hence only one gene can be expressed per
parental allele (Bartolomei et al., 1993). CTCF prevents de
novo DNA methylation of the imprint control region and thus
maintains the expression of the maternal H19 allele (Schoenherr
et al., 2003; Fedoriw et al., 2004). Furthermore, it was proposed
that CTCF insulates the maternal Igf2 promoter from the influ-
ence of these enhancers by positioning Igf2 in a transcription
inactive chromatin loop (Murrell et al., 2004).
The original suggestion for CTCF displaying an insulating
activity derived from an enhancer-blocking assay using a hyper-
sensitive site located upstream the chicken b-globin gene in
cultured cells. It was proposed that CTCF protects both b-globin
genes from being silenced by the surrounding heterochromatin,
and the neighboring olfactory receptors encoding genes from
being activated by the nearby erythroid-specific enhancers
(Bell et al., 1999). However, this function was challenged after
the deletion of Ctcf in erythroid cells did not lead to any ectopic
activation of genes adjacent to the b-globin locus (Splinter et al.,
2006).
Except for few studies where CTCF binding sites were either
deleted or mutated (Pant et al., 2004), CTCF function was rarely
approached in an organismal context. Analysis of mice carrying
aCtcf loss-of-function mutation in CD4+ T cells revealed that this
protein regulates cell cycle progression of ab T cells in the
thymus (Heath et al., 2008). Furthermore, the inactivation or
maternal depletion of Ctcf in murine oocytes leads to aberrant
meiosis and mitosis followed by apoptosis at the four-cell stage
(Fedoriw et al., 2004; Wan et al., 2008), illustrating that this
factor is essential for the survival of pre-implantation embryos.
In humans, mutations in several genes encoding proteins
involved in cohesion complex formation, such as Nipped-B-
Like, Smc1A, and Smc3, cause the Cornelia de Lange syndrome
(CdLS; Dorsett, 2007), whereas mutations in Esco2, a gene
encoding another regulator of the cohesin complex, are respon-
sible for the Roberts and SC phocomelia syndromes (Dorsett,
2007). Both types of patients display slow growth, mental retar-
dation, and limb defects (Dorsett, 2007). CTCF-dependent
changes in the expression of gene important for limb develop-
ment, in particular of Hox genes, were proposed to cause
the malformations observed in these patients (Dorsett, 2007;
Nasmyth and Haering, 2009).
Hox genes belonging to the HoxA and HoxD clusters indeed
play critical roles during limb development (Za´ka´ny andDuboule,
2007). Although the inactivation of both Hoxd13 and Hoxa13
results in a lack of digits (Fromental-Ramain et al., 1996),ntal Cell 19, 819–830, December 14, 2010 ª2010 Elsevier Inc. 819
Figure 1. CTCF Binding Sites in DevelopingMouse
Limbs
(A) A mouse forelimb bud at E10.75, hybridized with
a probe specific for Hoxa13, which indicates the future
autopod domain (hand). The dashed red line indicates
the plane of dissection. Scale bar represents 100 mm.
(B) A 2Mb large region is displayed as an example of CTCF
ChIP-chip on a high-density tiling microarrays covering
both chromosomes 2, X and Y. CTCF occupancy is shown
for the HoxD gene cluster as well as for four other genes
expressed ubiquitously: Atp5g3, Lnp, Mtx2, and Hnrpa3.
Hoxd13 to Hoxd10 are coexpressed in the developing
distal limb (distal to the plane of dissection), along with
both Evx2 and Lnp, under the control of enhancers located
centromeric (orange line). In parallel, Hoxd11 toHoxd9 are
coactivated in the proximal limb domain (proximal to the
dissection) by enhancers located telomeric to the cluster
(blue line).
(C) A higher magnification of (B) centered on the HoxD
cluster shows a high density of bound CTCF within this
gene cluster, with a clear bias toward the 50 half of the
cluster. The y axis indicates the ratio of ChIP-enriched/
input signal intensity, as determined by Bioconductor
for (B) or TAS for (C). The position of genes is displayed
according to NCBI build 35 of the mouse genome
sequence from UCSC genome browser (Kent et al., 2002).
(D) Distribution of CTCF binding sites relative to Refseq
genes on chromosomes 2 and X.
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Functions of CTCF during Limb DevelopmentHoxd11 and Hoxa11 compound mutants have severely trun-
cated zeugopod (forearm, foreleg) elements (Davis et al., 1995)
and the combined deletion of both the HoxA and HoxD clusters
almost completely abrogated limb development (Kmita et al.,
2005). In developing limb buds, the Hoxd1 to Hoxd11 genes first
follow a collinear and progressive activation in the presumptive
domain of the future forearm (Tarchini and Duboule, 2006).
Although the molecular mechanisms responsible for this early
phase of activation are as yet poorly understood, this early
expression of Hox genes contributes to the activation of Shh
within a small group of posterior mesenchymal cells, the zone
of polarizing activity (ZPA; Riddle et al., 1993; Tarchini et al.,
2006). SHH, a key molecule for limb outgrowth and patterning
(Riddle et al., 1993) is required for the maintenance of Fgf4
expression in the apical ectodermal ridge (AER; Laufer et al.,
1994). Regulatory interactions between SHH and FGF4 are
reciprocal, thus leading to a positive feedback loop that
promotes limb growth (Laufer et al., 1994; Zuniga et al., 1999).
Along with Shh transcriptional activation, a second phase of
Hoxd genes induction takes place in distal limb bud cells giving
rise to the future autopod (Tarchini and Duboule, 2006). This
phase involves from Hoxd10 to Hoxd13 and is controlled by
regulatory sequences located centromeric from the gene cluster
(Spitz et al., 2003; 2005; Gonzalez et al., 2007; Montavon et al.,
2008). Lnp and Evx2, two genes located immediately centro-
meric to the HoxD cluster, are coexpressed with Hoxd genes in
the autopod domain under the control of these potent
enhancers. The analyses of spontaneous and genetically engi-
neered mouse mutants have revealed the necessity for a tight
regulation of these two partially overlapping groups of Hoxd
genes, during these early and late phases, to achieve correct
limb development. It is particularly critical to isolate the most
posterior genes Hoxd12 and Hoxd13 from the early regulatory820 Developmental Cell 19, 819–830, December 14, 2010 ª2010 Elsinfluence, to prevent serious deleterious gain of function effects
(Peichel et al., 1997; Herault et al., 1997).
Because genome-wide studies identified CTCF binding sites
around and within the HoxD cluster in human cells (Kim et al.,
2007; Barski et al., 2007), this factor was proposed to function
as an insulator to help organizing these regulatory domains
(Kimet al., 2007). Themapping ofCTCFbinding sites toboundary
elements at the AbdominalB Hox gene locus in Drosophila
(Holohan et al., 2007) strengthened this assumption. In this study,
we report our investigations on the role of CTCF in Hoxd genes
regulation during limb development, in physiological conditions.
WemappedCTCFbinding sites in limbmesenchyme for10%of
the mouse genome. Using a limb conditional mutation of Ctcf
we identified presumptive target genes, suggesting a function
for this protein during limb development. However, neither
gene-expression profiling, nor transcriptome analysis indicates
that CTCF either directly regulates Hoxd genes, or plays a role
in insulating groups of genes from undesirable regulations.
RESULTS
Identification of CTCF Binding Sites in Limb
Mesenchyme
We mapped CTCF binding sites in mouse limb mesenchyme
using chromatin-immunoprecipitation, combined with DNA tiling
arrays (ChIP-chip). Chromatin extracts were prepared from the
distal part of embryonic limb buds, comprising both the future
autopod and zeugopod domains, at day 10.75 of development
(E10.75) (Figure 1A). Two biological replicates of ChIP material
were hybridized to high density tiling arrays containing nonrepe-
titive sequences from chromosomes 2, X and Y, i.e., >10%of the
mouse genome. The analysis of this data set for chromosomes 2
and X identified 908 enrichment peaks (Figures 1B and 1C), withevier Inc.
Figure 2. Conditional Inactivation of Ctcf in Developing Limbs
(A) b-galactosidase staining in a Prx1Cre:Ctcfflox/flox embryo, showing the
conditional deletion of Ctcf in both limb buds at E11.5. After Cre-mediated
recombination, LacZ becomes expressed under the control of the Ctcf
promoter. Because the Prx1Cre promoter is more efficient in forelimb buds
than in hindlimbs, the experiments were all carried out using forelimb bud
material. Scale bar represents 600 mm.
(B) Quantitative RT-PCR measuring Ctcf transcripts from either wild-type
(wt, blue), or Ctcf mutant (mut, red) forelimbs at E10.75. Relative Ctcf expres-
sion level in wild-type was arbitrarily fixed to 1. Error bars are ± SD, n = 3.
(C) Western blot analysis illustrating the almost complete loss of CTCF protein
in mutant limbs at E10.75. Tubulin was used as a loading control.
(D) Immuno-histochemical analysis shows the presence of CTCF in both
mesenchyme and ectoderm (arrowhead) in wild-type limbs at E10.75. Scale
bar represents 20 mm.
(E) CTCF was lost in a vast majority of mesenchymal cells, yet it remained
detectable in limb ectoderm (arrowhead) of Ctcf mutant embryos, a cell layer
where the Prx1Cre transgene is not active. Scale bar represents 20 mm.
(F) Venn diagram of CTCF binding events identified by ChIP-chip in wild-type
(blue) and Ctcf mutant (red) forelimb buds.
(G) ChIP-qPCR analysis for CTCF was performed in wild-type (blue) and
Ctcf mutant (orange) forelimb buds. CTCF positive (P) and negative (N) sites
have the following coordinates: P1 (Chr2:74588380), P2 (Chr2:74610200),
P3 (Chr2:74858500), P4 (Chr2:167135300), P5 (Chr2:168268600), P6
(ChrX:154036200), N1 (Chr2:74785900), N2 (Chr2:74807000). Site P4 (red)
represents a CTCF binding event identified by ChIP-chip in Ctcf mutant
forelimb buds. Enrichment is shown as a percentage of input. Error bars
are ± SEM, n = 2.
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Functions of CTCF during Limb Developmentpeak score ranging from 1.5 to 24.7 (log2 scale) and an average
height and width of 4.3 and 300 bp, respectively. We validated
these results by selecting 28 CTCF binding sites with low enrich-
ment scores (1.5 < x < 2) and 20 sites with higher enrichment
scores (x > 4.3) and performed quantitative polymerase chain
reaction (PCR) analysis on two independent limb bud samples.
Forty-six of forty-eight (95.8%) enrichment peaks were
confirmed (see Figure S1 available online).
The analysis of CTCF binding sites distribution relative to
annotated genes (Kent et al., 2002) revealed that a large number
of sites (64%) locates within intergenic regions (Figure 1D), 29%
within genes and 7% near transcription start sites (TSS), defined
here as within a one kb window from the TSS. The distribution of
peaks within genes and intergenic regions was as expected by
a random distribution, in contrast to the recruitments of CTCF
to the TSS, which was 5.8-fold higher than expected (pvalue <
1 3 1010, c2 test). However, binding of CTCF to GC-rich
sequences, which are overrepresented within promoters (CpG
islands), may explain this bias in peaks’ distribution.
We analyzed the HoxD cluster in some details by focusing on
a 2-mb large DNA interval. This highly syntenic region (Lee et al.,
2006a) contains the HoxD cluster, the tightly associated Evx2
gene as well as four ubiquitously expressed genes (Atp5g3,
Lnp, Mtx2, Hnrpa3) and two gene deserts on either sides with
ranges of highly conserved noncoding DNA elements, including
enhancer sequences responsible for transcriptional activation of
the Hoxd genes during limb development (Spitz et al., 2003;
Gonzalez et al., 2007) (Figure 1B). We detected four CTCF
binding sites 600 kb upstream the HoxD gene cluster and
seven sites downstream the cluster (Figure 1B). We considered
these as potential candidate sites to either insulate unrelated
genes from limb-specific enhancers, or to mediate long-range
chromosomal interactions to facilitate selective enhancers-
promoters contacts involving specific subset of Hoxd genes in
each limb domain. Accordingly, we found that seven of nine
Hoxd genes were flanked by CTCF binding sites (Figure 1C), in
particular immediately upstream the TSS of Evx2, Hoxd13, and
Hoxd12, supporting a role for CTCF either in the transcriptional
activation of these genes during digit development, or alterna-
tively, in their exclusion from the action of forearm enhancers.
CTCFbinding sites are generally common todifferent cell types
(Kim et al., 2007; Barski et al., 2007). We compared our data set
with that reported for mouse ES cells (Chen et al., 2008), where
neither Hoxd genes nor Evx2 are expressed and 14 of our 17
CTCF binding sites were also detected in ES cells (Chen et al.,
2008). Furthermore, most of these peaks were also detected in
various human cell lines (Kim et al., 2007; Barski et al., 2007).
However, the recruitment of CTCF to the promoter of Evx2 and
upstream Hoxd12 was specific for limb cells (Figure 1C).
Limb Defects in Ctcf Conditional Mutant Mice
We assessed the physiological importance of these CTCF
binding sites on the regulation of Hoxd genes by inactivating
Ctcf in limb mesenchyme, using a conditional deletion allele
(Heath et al., 2008), combined with a Cre transgene under
the control of the Prx1 promoter (Logan et al., 2002). After re-
combination between loxP sites flanking the second and the
last Ctcf exons, a lacZ reporter transgene becomes expressed
under the control of the endogenous Ctcf promoter (Figure 2A),Developmental Cell 19, 819–830, December 14, 2010 ª2010 Elsevier Inc. 821
Figure 3. CTCF Is Necessary for Cell Survival
During Development
Skeletal preparations of E14.0 wild-type (A and C) and
Prx1Cre:Ctcf flox/flox mutant (B and D) fore- (FL) and hin-
dlimbs (HL). (B) Except for a poorly determined piece of
proximal bone, likely part of the clavicle, skeletal elements
were absent from Ctcf mutant forelimbs. A schematic
drawing of wild-type limb skeletal elements is superim-
posed for comparison. (D) In hindlimbs, a partial deletion
of Ctcf induced generally ill-formed and shortened limbs,
with a reduced number of digits. Scale bars represent
500 mm.
(E–H) BrdU incorporation (red) showing normal prolifera-
tion in Ctcf mutant limb mesenchyme cells at E11.5.
DAPI staining (blue) shows nuclei. (G and H) Enlargements
of the areas boxed in (E) and (F). Scale bars represent
75 mm (E and F); 25 mm (G and H).
(I–L) TUNEL assay illustrating the extensive apoptosis in
mesenchyme of Ctcf mutant forelimbs at E11.5. (K) and
(L) are enlargements of the boxed areas in (I) and (J); see
also Figure S2. Scale bars represent 150 mm (I and J);
50 mm (K and L).
(M) CTCF ChIP-qPCR analysis for selected target genes
identified by expression arrays in wild-type (blue) and
Ctcf mutant (orange) limb mesenchyme. Enrichment is
shown as a percentage of input. Error bars are ± SEM,
n = 2.
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Functions of CTCF during Limb Developmentallowing for the visualization of mutant cells in the limbs. Using
quantitative RT-PCR we determined that at least 90% of Ctcf
RNA was depleted in mutant limbs, as compared to wild-type
at E10.75 (Figure 2B). Western blot confirmed the severe
reduction of CTCF protein levels in mutant limbs at the same
developmental stage (Figure 2C). Furthermore, immunohisto-
chemical analysis showed that CTCF was present in all cells
in wild-type limbs (Figure 2D), whereas a vast majority of mesen-
chymal cells were CTCF negative in mutant limbs (Figure 2E).
CTCF protein was expectedly scored in limb ectoderm (Fig-
ure 2E), where the Prx1Cre transgene is inactive. Importantly,
mutant and wild-type limbs were morphologically similar at this
developmental stage.
To further quantify the amount of CTCF left in our mutant
samples, we carried out an additional ChIP-chip experiment,
using Ctcf mutant limbs. This data set revealed that 96% of
CTCF binding events were lost in the mutant forelimbs at
E10.75 (Figures 2F and 2G). Analysis of the remaining 4% indi-
cated that these peaks may represent false positives, as they
partly overlap with low complexity or simple repeats regions.
We thus concluded that the amount of CTCF in our mutant822 Developmental Cell 19, 819–830, December 14, 2010 ª2010 Elsevier Inc.samples, if not totally abolished, is way below
the physiological concentration.
This massive decrease of CTCF lead to a
dramatic truncation of the forelimbs, with a
detectable size reduction as early as from
E11.5 onward. Alcian blue staining of E14.0
embryos indicated that mutant forelimbs lacked
all skeletal elements, including the scapula,
humerus, radius, ulna, and digits (Figures 3A
and 3B). Although hindlimbs were less severely
affected, due to the postponed and somewhatlower activity of the Prx1Cre transgene there (Logan et al.,
2002), mutant skeletal elements were still smaller than wild-
type (Figures 3C and 3D). To assess whether such a drastic
reduction in limb size was due to a deficit in cellular proliferation
or, alternatively, to increased apoptosis, we compared cell
proliferation and survival rates in mutant and wild-type embryos.
BrdU incorporation was comparable in normal and mutant
forelimbs at E11.5 (Figures 3E–3H), suggesting that proliferation
was not critically affected. In contrast, apoptosis was strongly
enhanced in mutant mesenchymal cells, when compared to
wild-type at E11.5 (Figures 3I–3L), indicating that cell survival
was strongly impaired in CTCF depleted cells. TUNEL positive
cells were found on both anterior and posterior sides of the
limb, indiscriminately, though with a higher occurrence within
areas of active proliferation.
We further analyzed the molecular consequences of such a
depletion of CTCF by genome-wide gene expression profiling
using RNA extracted from wild-type and mutant distal limb
buds at E10.75. We selected this early developmental stage to
look for direct effects, rather than secondary consequences of
size reduction, because only few apoptotic cells were scored
Developmental Cell
Functions of CTCF during Limb Developmentin both wild-type and mutant distal limbs (Figure S2). Pair-wise
comparison analyses revealed 220 downregulated and 177 up-
regulated genes, as defined by using a >1.5-fold difference
between mutant and wild-type limbs (Tables S1 and S2).
As anticipated from the phenotype, multiple genes encoding
apoptotic factors, mitochondrial proteins and enzymes respon-
sible for the reduction of oxidative stress were misregulated in
Ctcf mutant limbs (Table S3). Furthermore, genes encoding
factors involved in the G2/M transition checkpoint were overrep-
resented (11.7-fold) among deregulated genes, including Nibrin
(Nbn). Yet the largest group of misregulated genes (44 of 397)
was concerned with mitochondrial proteins. Although genes en-
coding subunits of themitochondrialmembrane respiratory chain
NADH dehydrogenase complexes (Ndufab1, Ndufb7, Ndufaf3,
and Ndufaf4), PAR glycohydrolase (Adprlh2), Frataxin (Fxn),
glutamate oxaloacetate transaminase 2 (Got2), inorganic pyro-
phosphatase 2 (Ppa2), and Sirtuin 5 deacetylase (Sirt5) were
downregulated, PUMA (Bbc3), which is responsible for the induc-
tion of cytochrome c release and apoptosis, was upregulated in
Ctcf mutant limbs. ChIP-qPCR analyses demonstrated that
CTCFwas recruited toTSSof all testeddownregulatedmitochon-
drial genes and Bbc3 in mouse limb mesenchyme (Figure 3M).
Effect of CTCF on Transcriptional Regulation
We determined the overall consequences of CTCF depletion on
the general transcriptional activity, i.e., including intergenic and
intronic noncoding transcripts (ncRNAs), by comparing total
RNAs from limb buds of both wild-type and mutant embryos,
using tiling arrays covering chromosomes 2, X and Y. Compara-
tive analyses of wild-type and mutant limbs transcript profiles
revealed only few differentially expressed genes. Of these,
42 were downregulated, whereas 48 were upregulated by >1.5-
fold (Tables S4 and Table S5), which represent 5% of all genes
located on chromosomes 2 and X. The changes in transcripts
abundance were arguably moderate, ranging from 1.5- to
2-fold. The resultsofRNA-chipassaywereconfirmedon17differ-
entially expressed genes by quantitative RT-PCR carried out on
three independent limb samples (Figure S3). Fifty-one of fifty-
nine (86.5%) genes scored by using the gene expression arrays
also appeared as differentially expressed when using RNA-chip
on chromosomes2 andX tiling arrays (Tables S1, S2, S4, andS5).
In contrast, only 65% of those genes identified by RNA-chip
were also scored when using the expression arrays. We looked
at the correlation between the presence (binding) of CTCF and
changes in gene expression. Nineteen genes (45%) detected
as being downregulated after CTCF depletion had CTCF re-
cruited to the transcription start site (TSS) in the wild-type condi-
tion, whereas nine (22%) had a CTCF binding site within 10 kb
from the TSS and 14 (33%) had CTCF binding site further than
10 kb from the TSS (Figure 4A), suggesting that a large fraction
of those genes downregulated in Ctcf mutant may represent
direct targets of CTCF. Likewise, 26% of all genes displaying
CTCF bound to their TSS were downregulated in the mutant
limbs, indicating that CTCF may exert part of its function by
directly activating target promoters.
Among these downregulated genes were Jag1 and Grem1
(Figures 4C and 4D), two genes with important functions during
limb development (Panman et al., 2006). We detected CTCF
recruitment to the TSS of Jag1 (Figure 4C), as well as to enhancerDevelopmesequences locatedwithin the Formin locus (Figure 4D), which are
required for the activation ofGrem1 in limbmesenchyme (Zuniga
et al., 2004). Moreover, several noncoding RNA genes, such as
small nucleolar RNAs, were bound by CTCF and downregulated
in Ctcf mutant limbs (Figure 4E; Table S1).
We also examined the effect ofCtcf loss of function on the tran-
scription of imprinted loci. The transcriptional activity within the
Gnas cluster (Williamson et al., 2004) was affected in mutant
limbs,whereweobserveda reducedexpressionof twopaternally
expressed transcripts, Nespas (Nesp antisense) and Exon 1A.
Accordingly, we identified two CTCF binding sites upstream of
the respective promoters (Figure 4F). Changes in gene expres-
sion were also detected within the Dlk1/Gtl2 imprinted locus, as
revealed by expression arrays (Table S6). All genes, including
paternally expressed Dlk1 and maternally expressed Gtl2 and
Rian, were downregulated >1.5-fold in Ctcfmutant limbs. At the
Igf2/H19 locus, we detected a reduced expression of H19, yet
without any visible gain of Igf2 expression (Table S6).
In contrast, only two of the upregulated genes (4%) had CTCF
bound near their transcription start sites, whereas 11 (23%) dis-
played CTCF binding within 10 kb from the TSS. Consequently,
35 upregulated genes (73%) were associated with a peak of
CTCF occurring >10 kb away from the TSS (Figures 4B and 4G).
Genes induced >2-fold belong to this latter category, suggesting
that their differential expression is a secondary effect, as sup-
ported by their specific expression in muscle (Dmd and Mtmr1)
or ectodermal cells (Gpc3, Gpc4, Dlx2, Eda2r). Noteworthy,
with the exception of Eif2s2 and Phf6, all upregulated genes
were either silent, or expressed at very low levels in wild-type
limbs (Figure 4G), making it likely that the observed changes in
expression are due to slight modification in the ratio between
cells of mesenchymal and nonmesenchymal origin.
Using the chromosomes 2, X and Y tiling arrays, we identified
a third class of genes withmodified transcriptional activity inCtcf
mutant limbs, i.e., those where differential regulation was
restricted to intronic sequences (Table S7; Figures 4H and 4I).
In all cases, intronic transcripts were downregulated in mutant
limbs. Twenty-one of these genes (50%), which were not
included in the 42 ‘‘downregulated’’ genes, displayed CTCF
binding within the gene body, 13 (29.5%) of which with the
binding event within the intron. This group of CTCF targets
mostly contained genes encoding multiple isoforms and tran-
scripts lost in the mutant configuration contained either exons
used for alternative initiation, cassette exons or retained introns
(Kent et al., 2002). However,1000 expressed genes located on
chromosomes 2 and X did not show splicing defects in mutant
limb cells, suggesting that CTCF does not play a generic role
in intron excision. Instead, it may regulate the production of
specific alternative transcript variants. In summary, CTCF was
found to predominantly activate (or derepress) transcription of
target genes during limb development. A large number of
CTCF-associated genes were not differentially expressed
between mutant and wild-type tissues, indicating that the
recruitment of CTCF to these sites is not required for proper tran-
scriptional regulation in limb mesenchyme.
Hoxd Genes Expression in Ctcf Mutant Limb
Genes located at the 50 extremity of the HoxD cluster, including
Evx2 and from Hoxd13 until Hoxd10 were bound by CTCF andntal Cell 19, 819–830, December 14, 2010 ª2010 Elsevier Inc. 823
Figure 4. Gene Expression in Ctcf Mutant
Limbs
(A) Distribution of DNA-bound CTCF relative to the
transcription start sites (TSS) of genes downregu-
lated in Ctcf mutant limbs at E10.75. CTCF is
found either at the TSS (45%), within a 10 kb
distance from the TSS (22%) or further away.
(B) Distribution of DNA-bound CTCF relative to the
TSS of genes upregulated in Ctcf mutant limbs at
E10.75.
(C–I) Transcript profiles on high-density tiling
microarrays covering both chromosomes 2, X
and Y using reverse-transcribed total RNA. The
ratio wt/mut signal is shown on the upper profile.
Examples are shown for the Jag1 (C), Grem1 (D),
ak007971 (E), Gnas (F), Itm2a (G), Ciz1 (H), and
p47 (I) genes, in wild-type (green) and Ctcfmutant
(magenta) limbs. Expression of Jag1 (C), Grem1
(D), ak007971 (E), Gnas (F) was downregulated
(blue), whereas that of Itm2a (G) was increased
(red) in Ctcf mutant limbs. (H and I) Transcription
within introns of the Ciz1 and p47 genes was
downregulated (blue) in Ctcf deficient limbs.
CTCF binding sites identified by ChIP-chip are
shown for each gene in wild-type (black peaks
on the profile at the bottom) orCtcfmutant (brown)
limbs. The distance between Grem1 gene and the
CTCF peak located in the intron 19 of Formin is
of 110 kb (D). The y axis indicates the ratio of
cDNA/genomic DNA or ChIP-enriched/input
signal intensity.
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Functions of CTCF during Limb Developmentdownregulated in mutant limbs (Figure 5A). In wild-type limb
buds, 50 Hoxd genes are transcribed in the autopod (the future
hand) with a strict graded quantitative regulation, Hoxd13 being
expressed the strongest whereas Hoxd9 is barely detectable
(Montavon et al., 2008) (Figure 5A). Because Evx2 is positioned
between Hoxd13 and the autopod specific enhancers, it also
falls under the influence of these global enhancers and is thus
concomitantly expressed in wild-type autopod (Spitz et al.,
2003; Gonzalez et al., 2007; Montavon et al., 2008; Figure 5A).
InCtcfmutant limbs, the transcription of Evx2 gene was signif-
icantly reduced (4.5-fold), whereas Hoxd13 transcription was
moderately changed (2.4-fold reduction) and that of Hoxd10
virtually unchanged (1.2-fold reduction; Figure 5B). In contrast,
RNA levels of the more proximally expressed Hoxd genes,
such as Hoxd9 and Hoxd8 were increased %3-fold in mutant824 Developmental Cell 19, 819–830, December 14, 2010 ª2010 Elsevier Inc.limbs (Figures 5A and 5B). Whole mount
in situ hybridization revealed that
Hoxd13 was expressed in a slightly
more restricted area of the posterior-
distal part of the developing limb in
mutants animals, when compared to
wild-type at E10.75 (Figures 5C and 5D).
Likewise,Hoxd10was detected in almost
all cells in wild-type limbs, whereas it
appeared downregulated in the anterior
part of the Ctcf mutant limbs (Figures 5E
and 5F). Altogether, the expression
patterns of autopod-specific genes,
such as Evx2 and Hoxd13 were qualita-tively similar to wild-type at E11.5 (Figures 5G–5J). Hoxd10 tran-
scripts were also found at similar levels in both the autopod and
posterior zeugopod domains in mutant and wild-type limbs at
E11.5 (Figures 5K and 5L). Therefore, during limb development,
the activation of Hoxd genes by enhancers located on either
sides of the gene cluster is largely independent from CTCF.
The ectopic (or elevated) expression of Hoxd9 was not
observed in Ctcf mutant limbs, when compared to wild-type at
E11.5 or E10.75 (Figures 5M and 5N; Figures S4A and S4B).
Furthermore, we did not detect ectopic expression of Evx2,
Hoxd13 or of any other Hoxd genes analyzed, in either the
zeugopod (forearm) or stylopod (arm) domains, indicating that
CTCF bindingwithin theHoxD cluster is not necessary to insulate
posterior Hoxd genes from the influence of the early limb
enhancers.
Figure 5. Hoxd Genes Expression in Developing
Ctcf Mutant Limbs
(A) Transcript profiles on high-density tiling microarrays
covering chromosomes 2, X and Y using reverse-
transcribed total RNA. Transcription of Hoxd genes is
compared between wild-type (green) and Ctcf mutant
limbs (magenta). Expression of Evx2, Hoxd13, to Hoxd10
genes was reduced in the mutant condition (blue),
whereas steady state levels of Hoxd9 and Hoxd8 tran-
scripts were slightly increased (red) in Ctcf mutant limbs.
CTCF binding sites identified by ChIP-chip are shown for
each gene in wild-type (black) or Ctcf mutant (brown)
limbs. The y axis indicates the ratio of cDNA/genomic
DNA or ChIP-enriched/input signal intensity.
(B) Quantitative RT-PCR analysis of Hoxd genes expres-
sion inCtcfmutant limbs at E10.75. Data represent relative
expression levels for each gene, as compared to wild-
type. Relative expression levels of each gene in wild-
type were fixed to 1. Error bars are ± SD, n = 3.
(C–F) Expression patterns of Hoxd13 (C and D) and
Hoxd10 (E and F) genes in wild-type and mutant forelimb
buds at E10.75 (see also Figures S4A and S4B).
(G–N) Expression patterns of Evx2 (G and H), Hoxd13
(I and J), Hoxd10 (K and L), and Hoxd9 (M and N) genes
in wild-type and mutant forelimb buds at E11.5 (see also
Figures S4C–S4F). In Ctcf deficient limbs, the levels and
the spatial distribution of transcripts remained similar to
that in wild-type for all genes examined. Noteworthy, the
most distal domain (autopod) was reduced in Ctcf mutant
limbs when compared to wild-type at E11.5. Limb buds
are oriented with anterior at the top. Scale bars represent
200 mm.
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The severe distal truncation of the limb, added to a decrease in
the transcription of 50Hoxd, Grem1, and Jag1 genes in mutant
limbs, suggested that the function of Sonic hedgehog (Shh)
had been affected. Accordingly, we scored a strong downregu-
lation of Shh in mutant limbs (Figures 6A and 6B). The expression
of Fgf4, a gene whose transcription in the apical ectodermal
ridge (AER) serves as an indicator of Shh activity (Laufer et al.,
1994) was also lost (Figures 6C and 6D). In contrast, Fgf8 expres-
sion in the AER was identical between mutant and wild-type
limbs (Figures 6E and 6F). Shh also regulates the expression of
Grem1 in distal limb mesenchyme (Zuniga et al., 1999), which
in turn is required to establish the expression domain of Jag1
(Panman et al., 2006). Consistently, the expression of both
Grem1 and Jag1 was strongly decreased in Ctcf mutant limbs
(Figures 6G–6J).
DISCUSSION
Genome-wide studies have identified >14,000 DNA sites occu-
pied by CTCF in different human and murine cells (Kim et al.,Developmental Cell 19, 819–2007; Barski et al., 2007; Chen et al., 2008).
However, the biological relevance of this bind-
ing was assessed in some details for a few
genes only, leading to different suggestions
regarding the function of this factor (Schoen-
herr et al., 2003; Fedoriw et al., 2004; Splinter
et al., 2006; Heath et al., 2008; Majumderet al., 2008; Ribeiro de Almeida et al., 2009; Hadjur et al.,
2009; Gomes and Espinosa, 2010). We looked at the function
of CTCF during early limb development in vivo, using a condi-
tional allele of Ctcf in mutant mice, and our mapping of CTCF
binding sites identified a majority of DNA fragments located
within intergenic regions, far from gene promoters, in agreement
with previous studies (Kim et al., 2007; Barski et al., 2007; Chen
et al., 2008). Such target sites were proposed to function as
insulators, preventing the undesirable activation of genes by
tissue specific enhancers located at their vicinity (Kim et al.,
2007).
This hypothesis naturally applied to gene members of the
Hoxd cluster, because a clear partition must exist between ex-
pressed and nonexpressed neighboring genes to properly build
and pattern our appendages (Za´ka´ny and Duboule, 2007). In
addition, these complex regulations occur in a genomic region
rich in CTCF binding sites and via long-range acting enhancer
sequences. However, despite this paradigmatic situation for
CTCF acting as an insulator protein, our data do not support
this hypothesis and altogether show no evidence for such a
function of CTCF, at least in developing limb mesenchyme.830, December 14, 2010 ª2010 Elsevier Inc. 825
Figure 6. Distal Development in Ctcf Mutant Limbs
(A–F) Expression of Shh in wild-type (A) and Ctcfmutant (B) embryos at E10.5.
Expression of Shh was strongly downregulated in posterior mutant mesen-
chyme cells. (C and D) Fgf4 was lost in the AER of Ctcf mutant limbs
at E10.75, yet expression of Fgf8 was as in wild-type embryos at E10.75
(E and F).
(G andH) Expression patterns ofGrem1 in wild-type andCtcfmutant forelimbs
at E10.75.
(I and J) Jag1 expression was downregulated in mutant limb, when compared
to wild-type limbs at E10.75. The limb buds are oriented with anterior at the
top. Scale bar represents 100 mm.
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826 Developmental Cell 19, 819–830, December 14, 2010 ª2010 ElsExpression of Evx2 and 50Hoxd genes, such as Hoxd13 and
Hoxd12, was indeed still restricted to the distal part of the limb
in Ctcf mutant fetuses, much like in wild-type limb buds. This
result shows that CTCF is not required for blocking the activation
of either Hoxd13, or Hoxd12 in the proximal limb domain (the
future forearm) by the early limb enhancers located telomeric
to the gene cluster, as suggested by both the presence of
CTCF binding sites at the expected locations and the previous
observation that these enhancers are capable to ectopically
induce the expression of these two genes under experimental
conditions (Za´ka´ny et al., 2004; Tarchini and Duboule, 2006).
Likewise, Hoxd genes expressed in the future forearm region,
such as Hoxd8 or Hoxd9, were not dramatically upregulated in
most distal cells, after depletion of CTCF, and remained mostly
silent in this domain. Therefore, the strict topographic dichotomy
inHoxd gene regulation, necessary for proper limb development,
was not affected in Ctcf mutant appendages. The remaining
low amount of CTCF can hardly account for this result. First,
only 10% of cells with the floxed Ctcf allele still contained
enough CTCF to be detected by immunohistochemistry and,
consequently, any potential gain of function occurring in
CTCF-negative cells should have been scored in our assay.
Second, >10% of peaks remained in our mutant samples,
when analyzed for CTCF binding events by ChIP.
Multiple CTCF binding sites were also detected at the three
paralogous loci, i.e., within the HoxA, HoxB, and HoxC gene
clusters (Kim et al., 2007; Barski et al., 2007; Chen et al.,
2008), as well as within the AbdominalB (AbdB) gene locus in
Drosophila (Holohan et al., 2007), which is the gene cognate of
posterior (Hoxd13 to Hoxd9) Hox genes in mammals. Yet again,
the expression patterns of both Hoxa13 and Hoxa11 remained
mostly unchanged in Ctcf mutant limbs, when compared to
wild-type (Figures S4C–S4F). Likewise, we did not detect any
ectopic induction of either Hoxb or Hoxc genes in Ctcf mutant
limb mesenchyme. This is similar to the case of Drosophila
CTCF, which binds Fab-8, an insulator element required for the
restricted expression of AbdB in the most posterior segments
of Drosophila embryo (Moon et al., 2005; Holohan et al., 2007).
However, AbdB is not expressed ectopically in embryos lacking
CTCF. Instead, CTCF is required for the maintenance of AbdB
expression in its normal domain (Mohan et al., 2007).
Furthermore, mutant limb cells did not overexpress any gene
located nearby strongly expressed loci known or suspected
to be under the control of remote limb enhancers, including
Shh (Lettice et al., 2003), Grem1 (Zuniga et al., 2004), Bmp2
(Dathe et al., 2009), Gli3 (Abbasi et al., 2010), or the HoxA genes
(Lehoczky and Innis, 2008), supporting the conclusion that the
precise partition between expressed and nonexpressed genes,
often interspersed within one another at these various genomic
loci, does not depend (at least solely) on the presence of the
CTCF protein. The same conclusion was reached after looking
at some loci on chromosomes 2 and X, where no ectopic expres-
sion was detected for genes flanking transcriptionally active loci
and separated from themby aCTCF binding site(s). For instance,
olfactory gene clusters remained transcriptionally silent in Ctcf
mutant limbs, even though they flank genes highly expressed
in limb cells.
Altogether, expression analyses of genes playing key roles
during limb morphogenesis did not reveal any obviousevier Inc.
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mutant forelimbs. Whereas Shh expression was strongly weak-
ened, likely impacting on both Fgf4 and the absolute amount
of Hoxd transcripts, the phenotype of Shh full loss-of-function
in forelimbs is not as severe and hence this downregulation of
Shh may only account for part of the effect. We thus conclude
that this striking phenotype is caused by massive cell death,
resulting from impairment in a basic cellular process(es), rather
than by the misregulation of critical ‘‘limb patterning’’ genes,
due to the depletion of CTCF.
In contrast, a clear effect was scored on the transcriptional
activation and maintenance of those genes with a TSS bound
by CTCF. Within this group, the number of downregulated
transcription units was 9-fold higher than the upregulations.
CTCF associates with RNA Pol II complexes (Chernukhin et al.,
2007) and maintains the expression of imprinted genes by pro-
tecting their GC-rich promoters from de novo DNA methylation
(Schoenherr et al., 2003; Fedoriw et al., 2004). Accordingly,
several imprinted genes, expressed either from the maternal or
the paternal alleles, were downregulated in Ctcf mutant cells. It
was also proposed that CTCF blocks the spreading of a silencing
chromatin domain from the neighboring genes or intergenic
regions into transcriptionally active loci that escape X chromo-
some inactivation (Filippova et al., 2005). We did not detect
any significant loss of expression for genes located on the X
chromosome within regions escaping X-inactivation in female
Ctcf mutant limbs.
The largest group of downregulated genes in Ctcf mutants
limb was composed of nuclear genes encoding mitochondrial
proteins. These genes are transcriptionally coregulated and the
analyses of their core promoters revealed the presence of an
ATGGCGG motif (Cunningham et al., 2007), a sequence both
known to recruit the transcription factor YY1, and part of the
CTCF binding site (Kim et al., 2007; Barski et al., 2007). Our
data and genome-wide mapping of CTCF binding sites in human
resting CD4+ T cells (Barski et al., 2007) show that all nuclear
genes encoding mitochondrial proteins, which are downregu-
lated in Ctcf deficient limb mesenchyme, have CTCF bound
to their TSS. It is thus possible that CTCF controls cellular
homeostasis by directly regulating the transcription of various
mitochondrial genes.
Multiple lines of evidence suggest that CTCF is essential for
cell survival (Fedoriw et al., 2004; Wan et al., 2008). Consistent
with Gomes and Espinosa (2010), we show that the pro-
apoptotic gene Bbc3 (PUMA) is likely a direct target of CTCF-
mediated repression in limb mesenchyme. Gene expression
analysis on chromosomes 2 and X revealed only two genes
with CTCF bound at their TSS and upregulated in Ctcf mutant
limbs, supporting the observation that only a few silent genes
display CTCF on their TSS. In fact, the proportion, rather than
absolute number, of genes with CTCF at their promoters, which
were expressed in control limbs and downregulated in the
mutant counterparts was comparable to the proportion of silent
genes upregulated in the mutant situation, indicating that CTCF
can likely function either as a transcriptional activator or
repressor, depending on the recruitment of additional factors.
One-third of CTCF binding sites resides within introns (Kim
et al., 2007; this study) and we identified genes showing a down-
regulation of intronic transcripts only, in CTCF depleted cells. It isDevelopmethus possible that CTCF activates transcription from cryptic
promoters within introns, leading to poorly abundant, noncoding
transcripts. Alternatively, CTCF might affect the pre-mRNA
splicing by controlling the rate of RNA polymerase II elongation
or by recruiting chromatin-modifying enzymes (de la Mata
et al., 2003; Luco et al., 2010). The presence of various modifica-
tions on histone H3 has been recently associated with either the
presence or the absence of alternative exons in mRNAs (Luco
et al., 2010) and the correlation between CTCF binding and the
tri-methylation of H3K4 at the promoters (Wang et al., 2008)
suggests that CTCF could facilitate the positioning of this histone
mark over alternatively spliced exons.
EXPERIMENTAL PROCEDURES
Mouse Lines and Genotyping
The Ctcf loxP and Prx1Cremouse lines were described previously (Heath et al.,
2008; Logan et al., 2002). Conditional deletion of Ctcf in the limb mesenchyme
was achieved by crossing Prx1Cre:Ctcf loxP heterozygous males with Ctcf loxP
heterozygous females. Genotyping of embryos was performed by PCR
analysis with the following primers: CTCFfwr: 50-GAACGAACTAGGCTCAAGA
GAG-30; CTCFrev: 50-GTGGGCTTCCGGAATAGCTTCC-30; Prx1fwr: 50-GGT
CTGTAAAACGTCAGGCG-30; Crerev: 50-GCGATCCCTGAACATGTCCATCA
G-30; lacZfwr: 50-GTTAACCGTCACGAGCATCA-30; lacZrev: 50-TCACACTCG
GGTGATTACGA-30.
ChIP-Chip
Limb budswere dissected from E10.75mouse embryos, fixed in 1% formalde-
hyde for 15min at room temperature, washed three times with cold phosphate
buffer solution (PBS) and stored at80C. Pools of 16 limb buds were used for
each ChIP-chip experiment. ChIP was performed according to (Lee et al.,
2006b) using 2 mg of anti-CTCF antibodies (A300-543A, Bethyl Laboratories)
and EZview Red Protein G/A Affinity Gel (Sigma). Immunoprecipitated and
whole cell extract DNA (input) were treated with RNaseA, proteinase K and
purified by two rounds of extraction with phenol/chloroform/isoamyl alcohol.
ChIP and input DNA were amplified using ligation-mediated PCR (Lee et al.,
2006b). PCR was limited to 15 cycles. ChIP (1.5 mg) and input DNA were frag-
mented and labeled using GeneChip WT Double-Stranded DNA Terminal
Labeling Kit (Affymetrix) and hybridized to the Chromosome 2 and X tiling
arrays (Affymetrix). The arrays are based on NCBI build 33 of the mouse
genome (mm5) and contained >6.5 million perfect match oligonucleotide
probes positioned every 35 bp mapping to the reverse strand Chromosome
2 and X. Two independent ChIP-chip experiments were performed.
Gene Expression Profiling
Limb buds were dissected from E10.75 mouse embryos and stored in
RNAlater reagent (QIAGEN), for genotyping. For each replicate, RNA was
isolated from pools of six limb buds either of wild-type or homozygous
mutants, using RNeasy micro-kit (QIAGEN). cRNA was synthesized according
to the manufacturer’s instructions (Ambion) and hybridized to the GeneChip
Mouse Genome 430 2.0 Arrays (Affymetrix), which interrogates 39,000
transcripts. Three independent RNA extractions, cDNA synthesis and array
hybridizations were performed. The expression arrays data were normalized
and scaled to signal intensity of 100 using GCOS 1.2 software (Affymetrix).
Expression levels were analyzed using GeneSpring software (Silicon Genetics,
Redwood City, CA) and MATLAB 2009 (The MathWorks, Natick, MA). A 77%
cutoff in consistency of change (at least seven of nine comparisons were either
increased or decreased) was applied. Only genes that satisfied the pair-wise
comparison test and displayedR1.5-fold change in expression were consid-
ered for further analysis. Gene ontology analysis was performed using the
database for annotation, visualization and integrated discovery (DAVID)
(Huang da et al., 2009).
Transcript Profiling Using Chromosome 2 and X Tiling Arrays
Limb buds were dissected from E10.75 mouse embryos and stored in
RNAlater reagent (QIAGEN), for genotyping. For each replicate, RNA wasntal Cell 19, 819–830, December 14, 2010 ª2010 Elsevier Inc. 827
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using RNeasy micro-kit (QIAGEN). rRNA was depleted using RiboMinus
Human/Mouse Transcriptome Isolation Kit (Invitrogen). After cRNA amplifica-
tion, single or double-stranded cDNA was generated using The GeneChip
Whole Transcript Amplified Double-Stranded Target Assay kit (Affymetrix)
according to manufacturer’s instructions. cDNA was fragmented and labeled
using GeneChip WT Double-Stranded DNA Terminal Labeling Kit (Affymetrix)
and hybridized to oligonucleotide tiling arrays. The control genomic DNA
samples were fragmented with DNase I. Three independent RNA extractions,
cDNA synthesis and array hybridizations were performed.
Analysis of Tiling Array Data
Tiling arrays data were quantile normalized within cDNA/genomic DNA or
ChIP/input replicate groups using R packages, STARR and Ringo (Zacher
et al., 2010; Toedling et al., 2007). The ratio of probe intensity between the
experiment and the control groups were computed considering the median
values over replicates. The ratios were smoothened by computing the running
medians with a half window size set to 150 bp and a minimum of five probes
per window. To identify enriched regions a minimum of three consecutive
probes with a smoothed ratio exceeding a threshold have been considered.
The threshold has been fixed by taking the 99th percentile of the estimated
null distribution of the ratios. Only ChIP enriched regions with score log2 R
1.5 and widthR 150 bp were considered for further analysis. RNA-chip data
were computed at the exon level, by averaging the normalized intensities of
all probes falling within the exon. As a complement, array data were quantile
normalized within cDNA/genomic DNA or ChIP/input replicate groups and
scaled to medial feature intensity of 10 (transcriptome) or 500 (ChIP-chip)
using TAS software (Affymetrix). For each genomic position, a data set was
generated consisting of all probes mapping within a sliding window of 80 bp
(transcriptome) or 250 bp (ChIP-chip). The averaged ratios were plotted along
the genomic DNA sequence using Integrated Genome Browser (IGB) software
(Affymetrix).
ChIP-Quantitative Real-Time PCR and Quantitative
Reverse-Transcription PCR of mRNA Analyses
To obtain material for homozygous mutants, each pair of limb buds was
processed separately and pooled after genotyping. For qRT-PCR, around
150 ng of total RNA from wild-type and Ctcf mutant limbs was reverse
transcribed using random primers (Invitrogen). Expression changes were
then normalized to Rps9. PCR primers were designed using Primer Express
2.0 software (Applied Biosystems). ChIP, total genomic DNA (input), and
cDNA were PCR amplified using SYBR green containing qPCR master mix
kit (Eurogentec) with iCycler (Bio-Rad). A mean quantity was calculated from
triplicate reactions for each sample. Primers used are listed in Tables S8–S10.
Histological Techniques and In Situ Hybridization
Wild-type and mutant embryos (n R 5) were age-matched according to
their somite numbers, fixed in 4% formaldehyde in PBS, and processed for
paraffin wax embedding. Immunohistochemical analyses were performed on
5-mm paraffin sections using 1:500 anti-CTCF antibody (A300-543A Bethyl
Laboratories) and Vectastain Elite ABC kit (Vector Laboratories) according to
the manufacture’s instructions. BrdU was detected using a 1:250 anti-BrdU
antibody (Invitrogen), followed by 1:300 Cy5-conjugated goat anti-mouse
secondary antibody (Invitrogen). Apoptotic cells were detected using a
DeadEnd Colorimetric TUNEL System (Promega) according to manufacture’s
instructions. b-galactosidase staining of embryoswas performed as described
(Spitz et al., 2003). Skeletons of E14.0 embryos were prepared and stained
with Alcian blue 8GX. Whole-mount in situ hybridization was performed using
digoxigenin-labeled (DIG) RNA probes (Roche) as described (Spitz et al.,
2003).
Western Blot
Limb buds were dissected from E10.75 mouse embryos and stored in PBS at
80C for genotyping. Protein lysates was isolated from pools of six limb buds
either of wild-type or homozygous mutants. CTCF protein was detected using
a rabbit anti-CTCF antibody (A300-543A, Bethyl Laboratories) and mouse
anti-tubulin (T5168 Sigma), with HRP-conjugated secondary antibodies
(Sigma) and ECL detection reagents (Perkin-Elmer).828 Developmental Cell 19, 819–830, December 14, 2010 ª2010 ElsACCESSION NUMBERS
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